[YTL] YoY TTM Result on 31-Mar-2005 [#3]

Stock
[YTL] YTL CORPORATION BHD
Announcement Date
27-May-2005
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2005
Quarter
31-Mar-2005 [#3]
Profit Trend
QoQ- -13.27%
YoY- -19.93%
Quarter Report
Latest QR
Upcoming QR
YTL's Result
YTL's Financial Summary
View:
Show?
TTM Result
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
Revenue 6,461,271 5,829,196 5,253,986 4,759,739 4,394,094 3,637,337 2,505,197 17.08%
PBT 1,867,792 1,442,686 1,452,436 1,269,695 1,186,244 960,022 753,808 16.31%
Tax -141,876 -308,526 -433,492 -708,457 -485,322 -482,573 -394,187 -15.64%
NP 1,725,916 1,134,160 1,018,944 561,238 700,922 477,449 359,621 29.84%
-
NP to SH 975,915 598,504 682,916 561,238 700,922 477,449 359,621 18.08%
-
Tax Rate 7.60% 21.39% 29.85% 55.80% 40.91% 50.27% 52.29% -
Total Cost 4,735,355 4,695,036 4,235,042 4,198,501 3,693,172 3,159,888 2,145,576 14.09%
-
Net Worth 7,324,927 6,865,703 5,763,852 4,506,100 4,970,464 4,725,065 4,078,457 10.24%
Dividend
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
Div 375,566 330,531 107,026 106,824 108,742 112,513 71,085 31.93%
Div Payout % 38.48% 55.23% 15.67% 19.03% 15.51% 23.57% 19.77% -
Equity
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
Net Worth 7,324,927 6,865,703 5,763,852 4,506,100 4,970,464 4,725,065 4,078,457 10.24%
NOSH 1,502,425 1,502,868 1,440,963 1,380,883 1,442,721 1,450,296 1,441,151 0.69%
Ratio Analysis
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
NP Margin 26.71% 19.46% 19.39% 11.79% 15.95% 13.13% 14.35% -
ROE 13.32% 8.72% 11.85% 12.46% 14.10% 10.10% 8.82% -
Per Share
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
RPS 430.06 387.87 364.62 344.69 304.57 250.80 173.83 16.28%
EPS 64.96 39.82 47.39 40.64 48.58 32.92 24.95 17.27%
DPS 25.00 21.99 7.50 7.74 7.50 7.76 5.00 30.73%
NAPS 4.8754 4.5684 4.00 3.2632 3.4452 3.258 2.83 9.47%
Adjusted Per Share Value based on latest NOSH - 1,380,883
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
RPS 58.21 52.52 47.34 42.88 39.59 32.77 22.57 17.08%
EPS 8.79 5.39 6.15 5.06 6.32 4.30 3.24 18.07%
DPS 3.38 2.98 0.96 0.96 0.98 1.01 0.64 31.93%
NAPS 0.6599 0.6186 0.5193 0.406 0.4478 0.4257 0.3675 10.23%
Price Multiplier on Financial Quarter End Date
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
Date 31/03/08 30/03/07 31/03/06 31/03/05 31/03/04 31/03/03 29/03/02 -
Price 1.39 1.28 0.96 1.06 0.86 0.64 0.92 -
P/RPS 0.32 0.33 0.26 0.31 0.28 0.26 0.53 -8.05%
P/EPS 2.14 3.21 2.03 2.61 1.77 1.94 3.69 -8.67%
EY 46.73 31.11 49.37 38.34 56.49 51.44 27.12 9.48%
DY 17.99 17.18 7.81 7.30 8.72 12.12 5.43 22.07%
P/NAPS 0.29 0.28 0.24 0.32 0.25 0.20 0.33 -2.12%
Price Multiplier on Announcement Date
31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 31/03/03 31/03/02 CAGR
Date 22/05/08 24/05/07 18/05/06 27/05/05 27/05/04 22/05/03 30/05/02 -
Price 1.40 1.61 0.95 0.97 0.81 0.60 0.93 -
P/RPS 0.33 0.42 0.26 0.28 0.27 0.24 0.53 -7.58%
P/EPS 2.16 4.04 2.00 2.39 1.67 1.82 3.73 -8.69%
EY 46.40 24.74 49.89 41.90 59.98 54.87 26.83 9.55%
DY 17.86 13.66 7.89 7.98 9.26 12.93 5.38 22.11%
P/NAPS 0.29 0.35 0.24 0.30 0.24 0.18 0.33 -2.12%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment